Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions

NCT01367652 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Letrozole
DRUG: Letrozole

Sponsor

Roxane Laboratories